The last-resort antibiotic colistin is still being traded and widely used for growth promotion and disease prevention in food-producing animals in some low- and middle-income countries. Which would provoke a health crisis, especially making highly infectious diseases (pneumonia, diarrhea etc) treatment impossible. A recent study published in the world The Lancet Microbes. One of the world’s leading medical journals with an impact factor of 86.2.
This study was carried out by researchers at the University of Agriculture, Faisalabad, Pakistan, and the University of Oxford, UK.
Dr Mashkoor Mohsin, the Associate Professor at the University of Agriculture, Faisalabad, and lead author of the study said that colistin is an extremely important antibiotic for humans and its use in animal farming has been banned by the WHO and many high-income countries in a bid to halt the spread of its
resistance among deadly superbugs.
A study did discover, however, that many of these nations continue to export colistin to low- and middle-income nations including Pakistan, Nigeria, and Bangladesh. Furthermore, the study found high-level resistance to colistin due to a gene called MCR-1 was frequently present in bacteria from humans, animals
(poultry production), and the environment in Pakistan. It has been observe that farmers using colistin have a limited understanding of the public health consequences of its use and highlights the importance of better hygiene farming practices.
These findings highlight the need for strong regulation and political commitment regarding reducing colistin import, manufacturing, and use in animals to avoid a health crisis.